Nyxoah Sa Quick Ratio (NYXH) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Nyxoah Sa  (NASDAQ: NYXH)

Nyxoah Sa's Quick Ratio

NYXH's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2025, Quick Ratio deteriorated to 0.61 a new company low.

Within Medical Equipment & Supplies industry 114 other companies have achieved higher Quick Ratio than Nyxoah Sa in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 1408 to 1929.

Explain Quick Ratio?
How much Cash & cash equivalents NYXH´s has?
What are NYXH´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NYXH Quick Ratio (Dec 31 2025)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Dec 31 2024)
Q4
Y / Y Current Liabilities Change 127.4 % 127.4 % 127.4 % 127.4 % 50.92 %
Y / Y Cash & cash equivalent Change -12.24 % -12.24 % -12.24 % -12.24 % 54.4 %
Quick Ratio MRQ 0.61 0.61 0.61 0.61 1.59
NYXH's Total Ranking # 1929 # 1408 # # #
Seq. Current Liabilities Change 0 % 0 % 0 % 127.4 % 0 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -12.24 % 0 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 115
Healthcare Sector # 596
Overall Market # 1929


Quick Ratio Statistics
High Average Low
1.59 1.1 0.61
(Dec 31 2024)   (Dec 31 2025)




Financial Statements
Nyxoah Sa's Current Liabilities $ 55 Millions Visit NYXH's Balance sheet
Nyxoah Sa's Cash & cash equivalent $ 34 Millions Visit NYXH's Balance sheet
Source of NYXH's Sales Visit NYXH's Sales by Geography


Cumulative Nyxoah Sa's Quick Ratio

NYXH's Quick Ratio for the trailling 12 Months

NYXH Quick Ratio

 (Dec 31 2025)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 127.4 % 113.57 % 95.31 % 74.97 % 41.54 %
Y / Y Cash & cash equivalent TTM Growth -12.24 % -0.41 % 20.31 % 47.94 % 2.11 %
Quick Ratio TTM 0.61 0.74 0.91 1.17 1.59
Total Ranking TTM # 3790 # 0 # # #
Seq. Current Liabilities TTM Growth 16.29 % 19.46 % 24.16 % 31.85 % 9.21 %
Seq. Cash & cash equivalent TTM Growth -3.37 % -3.26 % -3.16 % -3.06 % 9.66 %

Quick ratio ranking by company, industry and sector >> Back to NYXH Financial Strength Comparisons >> Go to Compare NYXH Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q4 2025 to $54.83 millions, cumulative Quick Ratio decreased to 0.61 below the Nyxoah Sa average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 188 other companies have achieved higher Quick Ratio than Nyxoah Sa. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 0 to 3790.

Explain Quick Ratio?
How much Cash & cash equivalents NYXH´s has?
What are NYXH´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 189
Healthcare Sector # 896
Within the Market # 3790


trailing twelve months Quick Ratio Statistics
High Average Low
0.61 0.61 0.61
(Dec 31 2025)  




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Genedx Holdings Corp   1.64 $ 171.282  Millions$ 104.504  Millions
Treace Medical Concepts Inc   1.58 $ 48.367  Millions$ 30.635  Millions
Glucotrack Inc   1.55 $ 7.383  Millions$ 4.773  Millions
Global Innovative Platforms Inc.  1.53 $ 0.018  Millions$ 0.012  Millions
Alphatec Holdings Inc   1.53 $ 160.806  Millions$ 105.419  Millions
Electromed Inc   1.46 $ 15.287  Millions$ 10.468  Millions
Qhslab Inc   1.41 $ 0.636  Millions$ 0.450  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  1.41 $ 10.412  Millions$ 7.405  Millions
Beyond Air Inc   1.38 $ 6.917  Millions$ 5.000  Millions
Tandem Diabetes Care Inc   1.37 $ 292.666  Millions$ 213.725  Millions
Neuronetics Inc   1.37 $ 34.134  Millions$ 24.960  Millions
Heartbeam Inc   1.35 $ 4.380  Millions$ 3.240  Millions
Envista Holdings Corporation  1.33 $ 1,211.700  Millions$ 913.100  Millions
Orthopediatrics Corp  1.32 $ 60.851  Millions$ 46.197  Millions
West Pharmaceutical Services Inc   1.32 $ 791.300  Millions$ 601.700  Millions
Sonoma Pharmaceuticals Inc   1.31 $ 5.374  Millions$ 4.096  Millions
Lucid Diagnostics Inc   1.25 $ 34.705  Millions$ 27.689  Millions
Lyra Therapeutics Inc   1.24 $ 15.893  Millions$ 12.782  Millions
Resmed Inc   1.19 $ 1,209.450  Millions$ 1,019.120  Millions
Cadre Holdings inc   1.18 $ 122.898  Millions$ 104.495  Millions
Tenon Medical Inc   1.17 $ 3.756  Millions$ 3.213  Millions
Sintx Technologies Inc   1.11 $ 4.140  Millions$ 3.733  Millions
Koru Medical Systems Inc   1.08 $ 8.872  Millions$ 8.194  Millions
Plus Therapeutics Inc   1.06 $ 13.114  Millions$ 12.314  Millions
Electrocore Inc   1.06 $ 11.611  Millions$ 10.973  Millions
Globus Medical Inc   1.06 $ 557.243  Millions$ 527.739  Millions
Positron Corporation  1.05 $ 2.520  Millions$ 2.402  Millions
Edap Tms Sa  1.04 $ 20.452  Millions$ 19.627  Millions
Cuprina Holdings cayman Limited  1.03 $ 2.491  Millions$ 2.422  Millions
Lifestance Health Group Inc   0.99 $ 248.642  Millions$ 251.962  Millions

Date modified: 2026-07-07T12:29:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.